Main competitors
P/E (N) Price to Book (N) PEG (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Dividend Yield (N) Capi.($)
45.52x3.52x0.09x8.83x53.14x57.13x-.--% 1.09B
42.74x6.7x2.08x10x36.07x36.79x0.03% 44.8B
15.94x3.85x0.2x5.69x12.52x13.68x1.88% 40.35B
-51.84x90.51x0.89x17.45x-57.65x-56.85x-.--% 30.05B
-17.5x1.03x3.83x4.48x-8.41x-6.72x-.--% 21.8B
27.64x2.7x0.59x5.7x15.82x19.56x-.--% 19.09B
22.04x2.59x-1.23x4.19x13.68x15.56x-.--% 16.72B
-329.09x11.81x6.73x27.33x1504.74x-330.09x-.--% 13.53B
-14.2x62.16x0.68x6349.59x-18.15x-13.7x-.--% 12.47B
-169.65x18.74x-1.97x41.3x-164.02x-149.63x-.--% 12.1B
13.65x3.52x1.36x3.8x9.01x10.14x-.--% 10.84B
-85.52x16.38x1.41x6.3x-94.18x-65x-.--% 9.9B
-218.52x17.22x2.52x20.18x359.27x-457.56x-.--% 8.48B
-7.79x - -0.25x - -6.9x-6.69x-.--% 8.28B
-16.81x15.13x-0x16.17x-22.99x-16.19x-.--% 8.14B
-32.3x - 0.99x - - - - 8.5B
-17.6x5.98x6.2x496.77x-15.33x-15.49x-.--% 7.87B
-9.86x-31.58x7.31x79.35x-10.67x-10.27x-.--% 7.84B
Average -44.62x 14.39x 1.75x 443.57x 94.47x -57.37x 0.11% 15.66B
Weighted average by Cap. -29.66x 17.83x 1.56x 326.19x 75.72x -37.35x 0.28%
Bio Therapeutic Drugs
SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW